S. 773Senate117th Congress (2021-2023)In Committee

A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

Sponsored by John ThuneSen. John Thune (R-SD)
Introduced March 16, 2021

AI-Generated Summary

Updated February 8, 2026 at 12:24 AM UTC

The bill lets certain hospitals keep their eligibility for the 340B drug discount program during the COVID‑19 public health emergency, even if they don’t meet the usual disproportionate‑share percentage requirement. It applies to hospitals that were already participating or had applied and were approved before or during the emergency. The change is temporary and only covers calendar quarters when the emergency is in effect.

Key Provisions

  • Creates an exception so that eligible hospitals are treated as covered entities for a quarter even if they fail the disproportionate‑share adjustment percentage requirement during the COVID‑19 emergency.
  • Specifies which hospitals qualify: those that were covered entities before the emergency or that applied, were approved, and began participation before or during the emergency.
  • Defines “applicable calendar quarter,” “covered entity,” and the COVID‑19 public health emergency for purposes of the exception.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

March 16, 2021

View full timeline
SenateIntro Referral

Introduced in Senate

March 16, 2021

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

March 16, 2021

Floor Debate

2 members

What members said about S. 773 on the floor

1 Republican1 Democrat
Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Mar 16, 2021

Mr. President, I rise to speak in support of the ``Help Independent Tracks Succeed (HITS) Act,'' which Senator Blackburn and I introduced today. Representatives Linda Sanchez (D-CA) and Ron Estes…

John Thune
Sen. John ThuneR-SD · Mar 16, 2021

Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued March 16, 2021

II

117th CONGRESS

1st Session

S. 773

IN THE SENATE OF THE UNITED STATES

March 16, 2021

Mr. Thune (for himself, Ms. Stabenow, Mr. Portman, Ms. Baldwin, Mrs. Capito, and Mr. Cardin) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID–19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

1.

Eligibility exception for the drug discount program due to the COVID–19 public health emergency

(a)

In general

Notwithstanding any other provision of law, a hospital described in subsection (b) that, for an applicable calendar quarter, otherwise meets the requirements for being a covered entity under subparagraph (L), (M), or (O) of subsection (a)(4) of section 340B of the Public Health Service Act (42 U.S.C. 256b) and is in compliance with all other requirements of the program under such section, but that, for such calendar quarter, does not meet the applicable requirement for the disproportionate share adjustment percentage described in subsection (c), shall be deemed a covered entity under such respective subparagraph for such applicable calendar quarter.

(b)

Hospitals

A hospital described in this subsection is—

(1)

an entity that, on the day before the first day of the COVID–19 public health emergency, was a covered entity described in subparagraph (L), (M), or (O) of subsection (a)(4) of section 340B of the Public Health Service Act participating in the drug discount program under such section; or

(2)

an entity that—

(A)

prior to the COVID–19 public health emergency, submitted an application for participation in such program as a covered entity described in subparagraph (L), (M), or (O) of section 340B(a)(4) of the Public Health Service Act;

(B)

prior to or during such emergency, was approved for such participation; and

(C)

during such emergency, began participating in such program.

(c)

Applicable requirement for disproportionate share adjustment percentage

The applicable requirement for the disproportionate share adjustment percentage described in this subsection is—

(1)

in the case of a hospital described in subsection (a) that otherwise meets the requirements under subparagraph (L) or (M) of section 340B(a)(4) of the Public Health Service Act, the requirement under subparagraph (L)(ii) of such section; and

(2)

in the case of a hospital described in subsection (a) that otherwise meets the requirements under subparagraph (O) of such section 340B(a)(4), the requirement with respect to the disproportionate share adjustment percentage described in such subparagraph (O).

(d)

Definitions

In this section:

(1)

Applicable calendar quarter

The term applicable calendar quarter means a calendar quarter for which eligibility for the drug discount program under section 340B of the Public Health Service Act (42 U.S.C. 256b) is based on a cost reporting period for which the COVID–19 public health emergency is in effect for all or part of such cost reporting period.

(2)

Covered entity

The term covered entity has the meaning given such term in section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b(a)(4)).

(3)

COVID–19 public health emergency

The term COVID–19 public health emergency means the public health emergency declared by the Secretary of Health and Human Services under section 319 of the Public Health Service Act (42 U.S.C. 247d) on January 31, 2020, with respect to COVID–19.